Research Article
The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas
Table 1
Clinicopathological characteristics of patients enrolled in the study.
| | Grade | Age (years) | Gender (M/F) | Ki67 values (%) | MGMT methylated cases | IDH1R132H |
| | III () | 49 (22–72) | 15/14 | 7.8 (1–50) | 19 (65,5%) | 16 (55,2%) | | IV () | 55 (24–78) | 62/44 | 10 (2–75) | 38 (39%) | 11 (11,5%) |
|
|
